As of 2025-05-17, the EV/EBITDA ratio of InterCure Ltd (INCR.TA) is -46.85. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INCR.TA's latest enterprise value is 349.61 mil ILS. INCR.TA's TTM EBITDA according to its financial statements is -7.46 mil ILS. Dividing these 2 quantities gives us the above INCR.TA EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 10.3x - 11.0x | 10.6x |
| Forward P/E multiples | 9.6x - 11.1x | 10.4x |
| Fair Price | (352.60) - 654.76 | 122.30 |
| Upside | -164.2% - 19.1% | -77.7% |
| Date | EV/EBITDA |
| 2025-03-04 | -48.52 |
| 2025-03-03 | -50.42 |
| 2025-03-02 | -49.78 |
| 2025-02-27 | -47.50 |
| 2025-02-26 | -47.95 |
| 2025-02-25 | -49.53 |
| 2025-02-24 | -50.02 |
| 2025-02-23 | -50.51 |
| 2025-02-20 | -50.80 |
| 2025-02-19 | -48.68 |
| 2025-02-18 | -49.19 |
| 2025-02-17 | -48.67 |
| 2025-02-16 | -49.87 |
| 2025-02-13 | -49.53 |
| 2025-02-12 | -49.32 |
| 2025-02-11 | -49.61 |
| 2025-02-10 | -50.90 |
| 2025-02-09 | -50.11 |
| 2025-02-06 | -51.30 |
| 2025-02-05 | -51.89 |
| 2025-02-04 | -49.85 |
| 2025-02-03 | -48.22 |
| 2025-02-02 | -49.40 |
| 2025-01-30 | -49.09 |
| 2025-01-29 | -50.23 |
| 2025-01-28 | -51.19 |
| 2025-01-27 | -51.24 |
| 2025-01-26 | -51.37 |
| 2025-01-23 | -50.99 |
| 2025-01-22 | -50.99 |
| 2025-01-21 | -50.99 |
| 2025-01-20 | -51.14 |
| 2025-01-19 | -51.68 |
| 2025-01-16 | -51.94 |
| 2025-01-15 | -50.67 |
| 2025-01-14 | -50.50 |
| 2025-01-13 | -50.40 |
| 2025-01-12 | -50.80 |
| 2025-01-09 | -50.54 |
| 2025-01-08 | -50.04 |
| 2025-01-07 | -49.95 |
| 2025-01-06 | -50.99 |
| 2025-01-05 | -51.04 |
| 2025-01-02 | -49.02 |
| 2025-01-01 | -49.21 |
| 2024-12-31 | -49.72 |
| 2024-12-30 | -48.07 |
| 2024-12-29 | -50.09 |
| 2024-12-26 | -50.99 |
| 2024-12-25 | -51.11 |